Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing

Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assay...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Peter U., Fischer, Kerstin, Curtis, Kurt C., Huang, Yuefang, Fetcho, Nicole, Goss, Charles W., Weil, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437184/
https://www.ncbi.nlm.nih.gov/pubmed/34181574
http://dx.doi.org/10.4269/ajtmh.20-1390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437184/
https://www.ncbi.nlm.nih.gov/pubmed/34181574
http://dx.doi.org/10.4269/ajtmh.20-1390

Ejemplares similares